Medinice S.A (ICE) - Total Assets
Based on the latest financial reports, Medinice S.A (ICE) holds total assets worth zł82.52 Million PLN (≈ $22.71 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Medinice S.A book value and equity for net asset value and shareholders' equity analysis.
Medinice S.A - Total Assets Trend (2016–2024)
This chart illustrates how Medinice S.A's total assets have evolved over time, based on quarterly financial data.
Medinice S.A - Asset Composition Analysis
Current Asset Composition (December 2024)
Medinice S.A's total assets of zł82.52 Million consist of 11.4% current assets and 88.6% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 10.5% |
| Accounts Receivable | zł701.00K | 0.8% |
| Inventory | zł0.00 | 0.0% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł28.18 Million | 32.5% |
| Goodwill | zł47.75 Million | 55.1% |
Asset Composition Trend (2016–2024)
This chart illustrates how Medinice S.A's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ICE market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medinice S.A's current assets represent 11.4% of total assets in 2024, a decrease from 60.8% in 2016.
- Cash Position: Cash and equivalents constituted 10.5% of total assets in 2024, up from 0.3% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 87.0% of total assets, an increase from 37.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 55.1% of total assets.
Medinice S.A Competitors by Total Assets
Key competitors of Medinice S.A based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
Polynovo Ltd
AU:PNV
|
Australia | AU$127.41 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.00 Billion |
|
Respiri Ltd
AU:RSH
|
Australia | AU$7.08 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Atomo Diagnostics Ltd
AU:AT1
|
Australia | AU$9.48 Million |
Medinice S.A - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.59 | 3.46 | 9.71 |
| Quick Ratio | 0.59 | 3.46 | 9.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł-709.00K | zł3.69 Million | zł12.03 Million |
Medinice S.A - Advanced Valuation Insights
This section examines the relationship between Medinice S.A's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.77 |
| Latest Market Cap to Assets Ratio | 1.71 |
| Asset Growth Rate (YoY) | 131.0% |
| Total Assets | zł86.60 Million |
| Market Capitalization | $148.26 Million USD |
Valuation Analysis
Above Book Valuation: The market values Medinice S.A's assets above their book value (1.71x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Medinice S.A's assets grew by 131.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medinice S.A (2016–2024)
The table below shows the annual total assets of Medinice S.A from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł86.60 Million ≈ $23.83 Million |
+130.99% |
| 2023-12-31 | zł37.49 Million ≈ $10.32 Million |
-10.51% |
| 2022-12-31 | zł41.90 Million ≈ $11.53 Million |
-14.80% |
| 2021-12-31 | zł49.18 Million ≈ $13.53 Million |
+135.08% |
| 2020-12-31 | zł20.92 Million ≈ $5.76 Million |
+79.06% |
| 2019-12-31 | zł11.68 Million ≈ $3.22 Million |
+54.72% |
| 2018-12-31 | zł7.55 Million ≈ $2.08 Million |
+54.02% |
| 2017-12-31 | zł4.90 Million ≈ $1.35 Million |
+236.62% |
| 2016-12-31 | zł1.46 Million ≈ $400.82K |
-- |
About Medinice S.A
Medinice S.A., a medical technology company, creates, develops, and commercializes minimally invasive solutions in cardiology and cardiac surgery. The company offers PacePress, a medical device to reduce the risk of complications following the implantation of cardiac electrotherapeutic devices, such as pacemakers or implantable cardioverter-defibrillators; CoolCryo, a cardiac cryoablation technol… Read more